Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001209191-23-054904

10% owner bought 454,545 shares at $11.00 ($4,999,995)

  • 10% owner acquired 2,112,555 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Longitude Capital Partners IV, LLC 10% owner 2023-11-07 Conversion +1,793,429 1,793,429 I: show line 1 in the form
Longitude Capital Partners IV, LLC 10% owner 2023-11-07 Conversion +319,126 2,112,555 I: show line 2 in the form
Longitude Capital Partners IV, LLC 10% owner 2023-11-07 Purchase +454,545 $11.00 $4,999,995 2,567,100 I: show line 3 in the form
Open-market purchases · 454,545 sh · avg $11.00 · $4,999,995

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Longitude Capital Partners IV, LLC 10% owner 2023-11-07 Conversion · Series A convertible preferred stock −18,999,999 0 I: show line 4 in the form
Longitude Capital Partners IV, LLC 10% owner 2023-11-07 Conversion · Series B convertible preferred stock −2,906,148 0 I: show line 5 in the form
Loading xslF345X05/doc4.xml…